Seller Compounds definition

Seller Compounds means SB1518 and SB1578.
View Source

Examples of Seller Compounds in a sentence

  • After the Regulatory Materials have been transferred to Buyer, Seller shall assist Buyer with the provision of data relating to adverse experiences for the Seller Compounds after such transfer to Buyer.

  • On or before the Closing Date, Seller shall provide Buyer with a summary of the information relating to the investigation and reporting of adverse experiences regarding Seller Compounds and any existing material safety data sheets with respect to the Seller Compounds as of the Closing Date.

  • Seller has delivered or made available all available clinical trial results and data, including raw data and reports (“Scientific Data”), created by Seller or any third party on behalf of Seller in connection with the Seller Compounds.

  • Additionally, after the transfer of the Regulatory Materials to Buyer, Seller shall provide Buyer with all adverse drug experience information brought to the attention of Seller with respect to the Seller Compounds, as well as any materials events and matters concerning or affecting the safety or efficacy of the Seller Compounds brought to the attention of Seller, via facsimile to the attention of Buyer.

  • Seller will cooperate with Buyer to ensure a smooth transition of the Program, and in obtaining the cooperation of Seller and its distributors and licensees of the Seller Compounds with the transfer of adverse experience reporting obligations from Seller to Buyer.

  • Until the earlier of (a) termination of diligence obligations pursuant to Section 2.14(b), and (b) such time as all Milestone Payments have been paid in full, Buyer shall send to Seller a status report of the development, manufacture and commercialization of Seller Compounds and Products and the status of efforts to achieve the Milestone Events in January and June of each year (each such report, an “Update Report”), with the first such Update Report due in January 2013.

  • After the Closing Date and until the Regulatory Materials are transferred to Buyer, Buyer agrees to submit to Seller all adverse drug experience information brought to the attention of Buyer with respect to the Seller Compounds, as well as any material events and matters concerning or affecting the safety or efficacy of the Seller Compounds brought to the attention of Buyer, via facsimile to the attention of Seller.

  • Within twenty (20) days after the Closing Date, Seller will forward to Buyer a complete copy of the Regulatory Materials for the Seller Compounds, as well as copies of all correspondence with, and periodic and other reports (including adverse event reports and the underlying data) to, Regulatory Authorities with respect to the Seller Compounds or Regulatory Materials.

Related to Seller Compounds

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Licensed Compound means [***].

  • Product Candidate means, [***].

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Compounds means any chemical entity and/or active ingredient which is a selective or non-selective TGR5 receptor agonist or [***], including any Derivative thereof, synthesized by TES or its Affiliates pursuant to work conducted under the Research Program.